The chief financial officer of a biotech company operates in one of the most scrutinized and time-pressured executive environments in the business world. Unlike CFOs in mature industries, a biotech CFO is rarely managing a stable, revenue-generating business. Instead, they are managing the runway of a company that may be years away from its first commercial product, while simultaneously navigating the capital markets, maintaining investor confidence, and ensuring the company has the financial resources to reach the next value-inflection point.
This environment creates extraordinary demands on the CFO’s time and attention. A skilled personal assistant is one of the most important investments a biotech CFO can make to remain effective across all of their responsibilities.
The Distinct Pressure Points of a Biotech CFO
Biotech CFOs face a pressure profile that is fundamentally different from their counterparts in other industries. Their primary concerns typically include:
Capital markets and fundraising: Whether navigating a follow-on offering, a partnership transaction, or an IPO, the biotech CFO is often the lead relationship manager with investment banks, institutional investors, and ratings agencies. These relationships require consistent, high-quality communication and significant scheduling coordination.
Financial milestone management: Clinical-stage companies have defined burn rates and cash runway projections that require constant attention. The CFO must ensure that board members, investors, and management are aligned on the company’s financial position relative to upcoming milestones.
Regulatory filing coordination: SEC filings, 10-K and 10-Q preparation, and proxy statement coordination all land on the CFO’s desk. Each of these has hard deadlines and requires coordinated input from legal, accounting, and operations teams.
Earnings calls and investor days: Public biotech companies hold quarterly earnings calls, and many host annual investor days that involve months of preparation. The CFO is typically the primary presenter on financial matters, and their preparation must be thorough.
Across all of these demands, time is the scarcest resource. A personal assistant who can effectively manage the CFO’s calendar, communications, and preparation logistics creates meaningful leverage.
What a Personal Assistant Does for a Biotech CFO
Calendar management with milestone awareness: The most important function a personal assistant provides is ensuring the CFO’s calendar reflects actual priorities. For a biotech CFO, this means building the schedule around financial reporting deadlines, investor conference appearances, board meeting cycles, and clinical readout windows. When a Phase III trial is expected to read out in six weeks, the personal assistant adjusts the calendar to create preparation time and protects the CFO from avoidable scheduling conflicts.
Investor relations coordination: Biotech CFOs receive a continuous stream of inbound interest from institutional investors, sell-side analysts, and investment banks. The personal assistant manages this flow, coordinates investor meeting schedules during non-deal roadshows, and ensures follow-up commitments are tracked and fulfilled.
Board meeting logistics: Biotech boards meet frequently, and CFO presentations require precision. The personal assistant coordinates the collection of financial data from the accounting team, ensures the presentation deck is reviewed and finalized on schedule, and manages the logistics of board meeting materials distribution.
Travel and conference management: Biotech-focused investor conferences such as JPMorgan Healthcare, the Goldman Sachs Biotech Conference, and regional healthcare investor days each require advance planning, one-on-one meeting scheduling, and travel logistics. A personal assistant managing this process ensures the CFO arrives at every conference prepared and with a productive meeting schedule.
Communications triage: The CFO’s inbox contains a mix of strategic, operational, regulatory, and routine communications. A personal assistant with good judgment can triage this volume, draft responses to routine inquiries, and surface the communications that require the CFO’s direct attention.
Building the Right Working Relationship
The CFO-assistant relationship works best when it is built on clarity and trust. The CFO should invest time early in the relationship to explain their priorities, communication preferences, and decision-making style. This upfront investment pays significant dividends as the assistant develops the institutional knowledge needed to anticipate needs rather than simply respond to requests.
Confidentiality is paramount in this relationship. The CFO has access to material non-public information, pending transaction details, and sensitive personnel matters. A personal assistant must demonstrate impeccable discretion and understand the specific categories of information that require careful handling.
For CFOs who are working in companies led by executives with strong operational support needs, it is worth understanding how assistant roles scale across the organization. Learning from how a biotech CEO support structure works can inform how the CFO builds their own support model, particularly in companies where the CEO and CFO share administrative resources.
Fractional and Virtual Support Options
Not every biotech CFO, particularly those at pre-revenue clinical-stage companies, has the budget for a full-time, in-office personal assistant. The growth of fractional and virtual executive assistant services has made it possible to access high-quality support at a more flexible cost structure.
Virtual assistants who specialize in the life sciences space bring familiarity with biotech terminology, regulatory calendars, and investor relations workflows that generic administrative support cannot match. Many biotech CFOs find that a well-matched virtual assistant provides 70 to 80 percent of the value of a full-time hire at a fraction of the cost.
According to Harvard Business Review, executives who invest in strong administrative support consistently outperform peers who do not, because delegation frees cognitive resources for the judgment-intensive decisions that most require senior leadership attention.
Integration with the Finance Function
A personal assistant to the CFO must also develop strong working relationships with the broader finance team. Controller reports, treasury analyses, and budget variance reviews all flow toward the CFO’s office. A personal assistant who understands the cadence of the finance function can help manage the inflow of this information, ensuring the CFO receives the right materials at the right time without being overwhelmed by a constant stream of ad hoc requests.
Similarly, relationships with external auditors, tax advisors, and banking partners often involve scheduling and coordination that the personal assistant can manage directly, freeing the CFO from administrative back-and-forth.
What to Look for When Hiring
When evaluating candidates for a personal assistant role supporting a biotech CFO, the most valuable attributes include:
Prior experience supporting a finance or C-suite executive in a regulated industry, comfort with financial reporting cycles and investor relations workflows, demonstrated ability to handle confidential information appropriately, strong written communication skills for drafting professional correspondence, and a proactive orientation that does not require constant direction.
Candidates who have previously supported executives at publicly traded life sciences companies are especially valuable, as they will already be familiar with SEC filing timelines, quiet period protocols, and the cadence of the investor conference calendar.
For additional context on how executive support structures scale across the biotech sector, exploring resources on large pharma CEO support models provides useful benchmarks, even for CFOs at smaller organizations.
The Return on Investment
The return on investing in strong personal assistant support for a biotech CFO is not difficult to calculate qualitatively. When a CFO is spending two hours per day managing scheduling, coordinating logistics, and handling routine correspondence, that is two hours per day not being spent on investor relationships, financial strategy, and the critical judgment calls that determine whether the company reaches its next milestone.
At a company where the difference between success and failure is often measured in months of runway, redirecting that time toward higher-leverage activity is one of the most impactful operational decisions the CFO can make.
Strong personal assistant support is not an overhead cost. In a biotech company operating under the time pressures of clinical development and capital markets scrutiny, it is a strategic investment in the effectiveness of the person who controls the company’s financial lifeline.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.